Boston Scientific Stock News

Rising incidence of heart failure and growing number of patients with recurrent arrhythmias across the globe are some of the factors attributing to the cardiac rhythm management (CRM) devices market growth positively. Cardiac Rhythm Management Devices Market size was valued

Transcatheter Aortic Valve Replacement Market is projected to boom at a CAGR +12% by the timeline of 2021-28. Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic valve

Implantable neurostimulation devices are used to modulate the nervous system in order to improve biological functions. The activity involves the modulation of electrical signals transferred from the brain to various organs and vice versa. The devices either function by stimulating

Deep brain stimulation is defined as a surgery that involves the implantation of an electrical device in the body. This device is responsible for sending electrical signals to the areas of brain, which are responsible for body movement. World Deep

Sumitomo Mitsui DS Asset Management Company Ltd lowered its position in shares of Boston Scientific Co. (NYSE:BSX) by 0.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,808 shares of the medical equipment providers stock after selling 766 shares during the []

Global Electroceutical Devices Market was valued US$ 17.1 billion in 2018, and is projected to exhibit a CAGR of 6.8% over the forecast period (2018 - 2026). As an alternative to drug-based therapies, electroceuticals are medical devices that use electrical

Bernardo Wealth Planning LLC acquired a new position in Boston Scientific Co. (NYSE:BSX) during the 3rd quarter, HoldingsChannel reports. The fund acquired 5,345 shares of the medical equipment providers stock, valued at approximately $231,000. Several other institutional investors have also modified their holdings of BSX. Pacer Advisors Inc. lifted its holdings in Boston Scientific by []

The global Fractional Flow Reserve market was valued at 54.7 Million USD in 2020 and will grow with a CAGR of 10.71% from 2021 to 2027. The fractional flow reserve market is portioned into obtrusive and non-intrusive checking. The intrusive

Cardiac Resynchronization Therapy Market impacting factors and changes in regulation in the domestic market are also discussed in the country section of the cardiac resynchronization therapy market report, which have an impact on the market''s current and future trends. Some

Due to the increasing prevalence of diseases of the urinary and gastrointestinal system, as well as the growing applications in emerging fields such as ophthalmology and neuroscience, the global non-vascular stents market is expected to achieve significant growth. The increasing

The Tumor Ablation Equipment Market Report 2021-2027 provides global market size, regional and national level market size, market segment growth, market share, competitive landscape, sales analysis, influence of domestic and global market participants, and value chain Detailed analysis of optimization,

Overview For various drug deliveries and sample processing, special purpose needles are used. A hypodermic needle is a hollow needle that is widely used with a syringe to administer or remove fluids from the body. It is used to transport liquids

The Embolization Particle Market Report 2021-2027 provides global market size, regional and national level market size, market segment growth, market share, competitive landscape, sales analysis, influence of domestic and global market participants, and value chain Detailed analysis of optimization, trade

In the last trading session, 11.52 million shares of the Boston Scientific Corporation (NYSE:BSX) were traded, and its beta was 0.84. Most recently the company’s share price was $40.23, and it changed around -$0.47 or -1.15% from the last close, which brings the market valuation of the company to $57.58B. BSX currently trades at a … Why Boston Scientific Corporation (NYSE: BSX) Stock Shouldn’t Be Ignored In 2021 Read More »

CHURCHILL MANAGEMENT Corp lifted its stake in shares of Boston Scientific Co. (NYSE:BSX) by 6.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 147,394 shares of the medical equipment provider’s stock after acquiring an additional 8,596 shares during the quarter. CHURCHILL MANAGEMENT Corp’s holdings […]